DK0807185T3 - Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus - Google Patents

Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus

Info

Publication number
DK0807185T3
DK0807185T3 DK96902922T DK96902922T DK0807185T3 DK 0807185 T3 DK0807185 T3 DK 0807185T3 DK 96902922 T DK96902922 T DK 96902922T DK 96902922 T DK96902922 T DK 96902922T DK 0807185 T3 DK0807185 T3 DK 0807185T3
Authority
DK
Denmark
Prior art keywords
new
lta
streptococcus
lipoteichoic acid
grop
Prior art date
Application number
DK96902922T
Other languages
English (en)
Inventor
Peter Truog
Peter Roethlisberger
Original Assignee
Lunamed Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunamed Ag filed Critical Lunamed Ag
Application granted granted Critical
Publication of DK0807185T3 publication Critical patent/DK0807185T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96902922T 1995-01-30 1996-01-24 Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus DK0807185T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95101208 1995-01-30
PCT/EP1996/000309 WO1996023896A1 (en) 1995-01-30 1996-01-24 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus

Publications (1)

Publication Number Publication Date
DK0807185T3 true DK0807185T3 (da) 2002-10-07

Family

ID=8218940

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96902922T DK0807185T3 (da) 1995-01-30 1996-01-24 Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus

Country Status (11)

Country Link
US (2) US6114161A (da)
EP (1) EP0807185B9 (da)
JP (1) JP3638955B2 (da)
CN (1) CN1113102C (da)
AT (1) ATE219146T1 (da)
AU (1) AU4714196A (da)
CA (1) CA2208780C (da)
DE (1) DE69621776T2 (da)
DK (1) DK0807185T3 (da)
ES (1) ES2178699T3 (da)
WO (1) WO1996023896A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0807185T3 (da) * 1995-01-30 2002-10-07 Lunamed Ag Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
DE19728900A1 (de) * 1997-07-07 1999-01-14 Henkel Kgaa Hydrophile Glykoside
CN101275143A (zh) * 1998-04-02 2008-10-01 俄克拉何马大学董事会 编码透明质酸合酶的核酸及其应用方法
ES2378227T3 (es) 2001-08-13 2012-04-10 University Of Florida Research Foundation, Inc. Materiales y métodos para favorecer la reparación del tejido nervioso
US7807618B2 (en) * 2002-05-20 2010-10-05 The Board Of Regents Of The University Of Texas System Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues
KR100443080B1 (ko) * 2002-07-11 2004-08-04 일동제약주식회사 콜레스테롤 저하능을 갖는 스트렙토코커스 페시움 균주
WO2004050846A2 (en) * 2002-12-02 2004-06-17 Biosynexus Incorporated Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
GB0717442D0 (en) 2007-09-07 2007-10-17 Isis Innovation Compositions and uses thereof
HUE038277T2 (hu) * 2009-07-15 2018-10-29 Aimm Therapeutics Bv Gram-pozitív baktériumokra specifikus kötõvegyületek
WO2011025286A2 (ko) * 2009-08-26 2011-03-03 주식회사 알엔에이 리포테이코익산 유래 당지질 및 이를 포함하는 조성물
EP2380565A1 (en) 2010-03-31 2011-10-26 Lunamed AG Compositions for dental treatment comprising Lipoteichoic acids or parts thereof like mono- or polyglycerphosphates
EP2500349B1 (en) * 2011-03-11 2015-05-06 Universitätsklinikum Freiburg Synthetic LTA mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections
EP2545911A1 (en) 2011-07-12 2013-01-16 Lunamed AG Use of Lipoteichoic Acid in the Treatment of Non-Encapsulated Cancer Cells
EP2545910A1 (en) 2011-07-12 2013-01-16 Lunamed AG Use of Lipoteichoic Acid in the treatment of cancer in an inflammatory state
EP2545909A1 (en) 2011-07-12 2013-01-16 Lunamed AG Combination of D-Amino Acids and Lipoteichoic Acid
EP2574237A1 (en) 2011-09-30 2013-04-03 Lunamed AG Use of a lipoteichoic acid, mono- or polyglycerophosphate for antibacterial pre-treatment and especially in medical devices
EP2589387A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
EP2589388A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a Teichoic acid for the treatment of malignant ascites
KR102259799B1 (ko) * 2018-06-01 2021-06-02 경희대학교 산학협력단 리포테이코익산, TNF-α 및 IFN-γ를 유효성분으로 함유하는 항암용 조성물
KR20190137397A (ko) * 2018-06-01 2019-12-11 경희대학교 산학협력단 리포테이코익산, TNF-α 및 IFN-γ를 유효성분으로 함유하는 항암용 조성물
CN115279380A (zh) 2019-12-27 2022-11-01 佰欧波利斯有限公司 来自双歧杆菌的脂磷壁酸的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729461A (en) * 1970-12-23 1973-04-24 Us Agriculture Synthesis of glycosyl glycerides
SU787414A1 (ru) * 1978-10-05 1980-12-15 Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им. М.В. Ломоносова Способ получени 1,2-ди-0-пальмитоил- 3-0-/6-0-(1,2-ди-0-пальмитоил- - глицеро-3-0-фосфорил)- - глюкопиранозил/- -глицерина
US4678773A (en) * 1983-08-26 1987-07-07 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
JPS61275217A (ja) * 1985-05-29 1986-12-05 Yakult Honsha Co Ltd グラム陰性桿菌感染症防御剤
JPS6456692A (en) * 1987-08-27 1989-03-03 Nisshin Oil Mills Ltd Production of sugar glycerol
JPS6467237A (en) * 1987-09-09 1989-03-13 Nisshin Oil Mills Ltd Novel surface active composition and emulsified composition combined therewith
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
WO1994020115A2 (en) * 1993-03-10 1994-09-15 Miles, Inc. Hyaluronic acid used as a cancer treatment
DK0807185T3 (da) * 1995-01-30 2002-10-07 Lunamed Ag Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus

Also Published As

Publication number Publication date
DE69621776D1 (de) 2002-07-18
CA2208780A1 (en) 1996-08-08
ATE219146T1 (de) 2002-06-15
JP3638955B2 (ja) 2005-04-13
CN1113102C (zh) 2003-07-02
DE69621776T2 (de) 2003-01-30
US6214978B1 (en) 2001-04-10
CN1173206A (zh) 1998-02-11
AU4714196A (en) 1996-08-21
EP0807185A1 (en) 1997-11-19
CA2208780C (en) 2010-03-30
US6114161A (en) 2000-09-05
EP0807185B9 (en) 2002-12-11
JPH11500901A (ja) 1999-01-26
ES2178699T3 (es) 2003-01-01
WO1996023896A1 (en) 1996-08-08
EP0807185B1 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
DK0807185T3 (da) Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus
GB8813766D0 (en) Essential fatty acid compositions
BG102312A (en) New derivatives of 5-oxy-deoaminyl 6-oxy-methyl erythronolide a, method for their preparation and application for the preparation of biologically active products
CY1112927T1 (el) Αντισωματα κατα της ανθρωπινης il-12
GB9519661D0 (en) Fatty acid treatment
ATE66350T1 (de) Suessware und verfahren zur herstellung derselben.
ES551563A0 (es) Procedimiento para la preparacion de un suplemento mineral masticable
IL69930A0 (en) Oral mopidamol preparations and their production
MY110734A (en) Improvements in or relating to dioic acids.
IL107255A0 (en) Chewable pharmaceutical compositions
NZ309829A (en) Vaccine composition containing polyribosylribitol phosphate and method for making same
EP0312086A3 (de) Polyschwefelsäureester von Bis-aldonsäureamiden und deren Derivaten, Verfahren zu ihrer Herstellung und Arzneimittel
DE3479189D1 (en) Pharmaceutical composition with special 1,2-diacyl-glycero-3-phosphocholines for the treatment of diseases of the stomach and the intestines
JPS5782322A (en) Novel immunostimulant sugar protein extracted from pneumonia bacillus,obtaining method, application as drug and composition containing same
DE3470277D1 (en) Dietetic composition
ES2009248A6 (es) Composicion dietetica a base de algas que contengan selenio.
HUT52476A (en) Process for producing side chain unsaturated 1 alpha-hydroxy-d-vitamin homologues and pharmaceutical compositions comprising such compounds
FR2658516B1 (fr) Nouveaux produits sterouides comportant un radical spiro en position 17, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
ATE135917T1 (de) Stabilisierte pharmaceutische zusammensetzung die nicht-glycozylierte, reduzierte rekombinante human il-2 umfasst und verfahren zu ihrer herstellung
ATE160788T1 (de) Dextranester, verfahren zu ihrer herstellung und ihre verwendung zur umhüllung oder einbettung von arzneimitteln
AU4294496A (en) Methods for the preparation of pure homologous series of mono to tetra fatty acyl esters of sugars; characterization of one antitumor component as maltose 1, 6, 6' tripalmitate: and pharmaceutical formulations useful in the treatment of cancer.
Boquet et al. Fragment beta of tetanus toxin forms channels in lipid vesicles at low pH.
MX9705082A (es) Composiciones para el suministro de antigenos.
GEP19981197B (en) Emulsion for Treatment of Ulcer Diseases